These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29030529)

  • 1. Microbiological Test Data-Assuring Data Integrity.
    Tidswell EC; Sandle T
    PDA J Pharm Sci Technol; 2018; 72(1):2-14. PubMed ID: 29030529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
    Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
    PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry.
    Brown H; Mahler HC; Mellman J; Nieto A; Wagner D; Schaar M; Mathaes R; Kossinna J; Schmitting F; Dreher S; Roehl H; Hemminger M; Wuchner K
    PDA J Pharm Sci Technol; 2017; 71(2):147-162. PubMed ID: 27789803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-destructive vacuum decay method for pre-filled syringe closure integrity testing compared with dye ingress testing and high-voltage leak detection.
    Simonetti A; Amari F
    PDA J Pharm Sci Technol; 2015; 69(1):108-22. PubMed ID: 25691719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Product Sterility Testing . . . To Test or Not to Test? That Is the Question.
    Daniell E; Bryans T; Darnell K; Hansen J; Hitchins VM; Saavedra M
    Biomed Instrum Technol; 2016 Apr; 50 Suppl 3():35-43. PubMed ID: 27100074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterility Testing of Injectable Products: Evaluation of the Growth-based BacT/ALERT® 3D™ Dual T Culture System.
    Kaiser SJ; Mutters NT; Backhaus J; Frank U; Günther F
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):568-576. PubMed ID: 27325593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amendments to sterility test requirements for biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(86):26162-75. PubMed ID: 22606719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory issues relating to herbal products-part 3: quality and its determination.
    Forte JS; Raman A
    J Med Food; 2000; 3(1):59-69. PubMed ID: 19281343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data.
    Gordon O; Goverde M; Pazdan J; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2015; 69(3):383-98. PubMed ID: 26048745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing.
    Allen LV
    Int J Pharm Compd; 2019; 23(4):299-303. PubMed ID: 31315081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Risk-based Approach to Setting Sterile Filtration Bioburden Limits.
    Yang H; Li N; Chang S
    PDA J Pharm Sci Technol; 2013; 67(6):601-9. PubMed ID: 24265301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sterilization--the microbiology between claim and reality].
    Spicher G
    Zentralbl Hyg Umweltmed; 1993 May; 194(3):223-35. PubMed ID: 8338612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Words Matter: A Commentary and Glossary of Definitions for Microbiological Quality.
    McDonnell G; Baseman H; Cordie-Bancroft L
    PDA J Pharm Sci Technol; 2021; 75(6):553-570. PubMed ID: 34845101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUCAST expert rules in antimicrobial susceptibility testing.
    Leclercq R; Cantón R; Brown DF; Giske CG; Heisig P; MacGowan AP; Mouton JW; Nordmann P; Rodloff AC; Rossolini GM; Soussy CJ; Steinbakk M; Winstanley TG; Kahlmeter G
    Clin Microbiol Infect; 2013 Feb; 19(2):141-60. PubMed ID: 22117544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
    Korbutt GS
    Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory challenges to global harmonization and expanded access to concentrates: how will regulators balance the increasing cost of new safety requirements with the desire to increase the availability of affordable product?
    Farrugia A
    Haemophilia; 2004 Oct; 10 Suppl 4():83-7. PubMed ID: 15479377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.